Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?

[1]  Jeffrey A. Cohen,et al.  Defining the clinical course of multiple sclerosis: the 2013 revisions. , 2014, Neurology.

[2]  Simon C. Potter,et al.  Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis , 2011, Nature.

[3]  O. Ciccarelli,et al.  Grey matter damage and overall cognitive impairment in primary progressive multiple sclerosis , 2011, Multiple sclerosis.

[4]  M. Freedman,et al.  Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases , 2011, The Lancet Neurology.

[5]  K. Hawker,et al.  Progressive multiple sclerosis: characteristics and management. , 2011, Neurologic clinics.

[6]  B. Trapp,et al.  Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients , 2011, Annals of neurology.

[7]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[8]  A Giorgio,et al.  Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis , 2010, Neurology.

[9]  P. Sørensen,et al.  Demyelination versus remyelination in progressive multiple sclerosis. , 2010, Brain : a journal of neurology.

[10]  R. Reynolds,et al.  A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis , 2010, Annals of neurology.

[11]  L. Krupp,et al.  A phase 3 trial of extended release oral dalfampridine in multiple sclerosis , 2010, Annals of neurology.

[12]  David H. Miller,et al.  Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial , 2010, The Lancet Neurology.

[13]  L. Peltonen,et al.  Lack of support for association between the KIF1B rs10492972[C] variant and multiple sclerosis , 2010, Nature Genetics.

[14]  C. Laule,et al.  Two-year study of cervical cord volume and myelin water in primary progressive multiple sclerosis , 2010, Multiple sclerosis.

[15]  R. Franklin,et al.  Stem cell transplantation in multiple sclerosis: current status and future prospects , 2010, Nature Reviews Neurology.

[16]  C. Polman,et al.  Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis , 2010, Multiple sclerosis.

[17]  A. Thompson,et al.  Early imaging predicts later cognitive impairment in primary progressive multiple sclerosis , 2010, Neurology.

[18]  P. Calabresi,et al.  Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double‐blind placebo‐controlled multicenter trial , 2009, Annals of neurology.

[19]  Massimo Filippi,et al.  A multiparametric evaluation of regional brain damage in patients with primary progressive multiple sclerosis , 2009, Human brain mapping.

[20]  W. Brück,et al.  Remyelination capacity of the MS brain decreases with disease chronicity , 2009, Neurology.

[21]  C. Polman,et al.  Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease. , 2009, Brain : a journal of neurology.

[22]  Hans Lassmann,et al.  The relation between inflammation and neurodegeneration in multiple sclerosis brains , 2009, Brain : a journal of neurology.

[23]  Guillermo Izquierdo,et al.  Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis , 2008, Proceedings of the National Academy of Sciences.

[24]  C. Duijn,et al.  Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis , 2008, Nature Genetics.

[25]  H. Lassmann.  The pathologic substrate of magnetic resonance alterations in multiple sclerosis. , 2008, Neuroimaging clinics of North America.

[26]  J. Lowe,et al.  Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[27]  Massimo Filippi,et al.  A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes , 2008, NeuroImage.

[28]  O. Ciccarelli,et al.  Predicting progression in primary progressive multiple sclerosis: A 10‐year multicenter study , 2008, Annals of neurology.

[29]  M. Battaglini,et al.  Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis. , 2008, Archives of neurology.

[30]  D. Arnold,et al.  Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions , 2008, Annals of neurology.

[31]  Marco Rovaris,et al.  Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis , 2008, Multiple sclerosis.

[32]  Roland Martin,et al.  Multiple sclerosis: a complicated picture of autoimmunity , 2007, Nature Immunology.

[33]  M. Filippi,et al.  In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study. , 2007, Brain : a journal of neurology.

[34]  A. J. Thompson,et al.  Localized grey matter damage in early primary progressive multiple sclerosis contributes to disability , 2007, NeuroImage.

[35]  D. Louis Collins,et al.  Voxel-based analysis of the evolution of magnetization transfer ratio to quantify remyelination and demyelination with histopathological validation in a multiple sclerosis lesion , 2007, NeuroImage.

[36]  R. Reynolds,et al.  Remyelination can be extensive in multiple sclerosis despite a long disease course , 2007, Neuropathology and applied neurobiology.

[37]  D. Chari,et al.  Remyelination In Multiple Sclerosis , 2007, International Review of Neurobiology.

[38]  Christine Stadelmann,et al.  Extensive Cortical Remyelination in Patients with Chronic Multiple Sclerosis , 2007, Brain pathology.

[39]  J. Geurts,et al.  Gray and normal-appearing white matter in multiple sclerosis: an MRI perspective , 2007, Expert review of neurotherapeutics.

[40]  W. L. Benedict,et al.  Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.

[41]  Hans Lassmann,et al.  Widespread Demyelination in the Cerebellar Cortex in Multiple Sclerosis , 2007, Brain pathology.

[42]  Hans Lassmann,et al.  Remyelination is extensive in a subset of multiple sclerosis patients. , 2006, Brain : a journal of neurology.

[43]  P. Matthews,et al.  Neocortical neuronal, synaptic, and glial loss in multiple sclerosis , 2006, Neurology.

[44]  B. Engelhardt,et al.  Dysferlin Is a New Marker for Leaky Brain Blood Vessels in Multiple Sclerosis , 2006, Journal of neuropathology and experimental neurology.

[45]  Mara Cercignani,et al.  Regional gray matter atrophy in early primary progressive multiple sclerosis: a voxel-based morphometry study. , 2006, Archives of neurology.

[46]  A. Thompson,et al.  Cord atrophy separates early primary progressive and relapsing remitting multiple sclerosis , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[47]  J. Haines,et al.  APOE epsilon variation in multiple sclerosis susceptibility and disease severity , 2006, Neurology.

[48]  S. Vukusic,et al.  Age at disability milestones in multiple sclerosis. , 2006, Brain : a journal of neurology.

[49]  Frederik Barkhof,et al.  MR spectroscopic evidence for thalamic and hippocampal, but not cortical, damage in multiple sclerosis , 2006, Magnetic resonance in medicine.

[50]  A J Thompson,et al.  Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: a tissue specific magnetisation transfer study , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[51]  Zografos Caramanos,et al.  1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic review. , 2005, Brain : a journal of neurology.

[52]  Hans Lassmann,et al.  Cortical demyelination and diffuse white matter injury in multiple sclerosis. , 2005, Brain : a journal of neurology.

[53]  F. Barkhof,et al.  Long-term clinical outcome of primary progressive MS: Predictive value of clinical and MRI data , 2005, Neurology.

[54]  Mara Cercignani,et al.  Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study. , 2005, Brain : a journal of neurology.

[55]  M. Rovaris,et al.  Axonal injury and overall tissue loss are not related in primary progressive multiple sclerosis. , 2005, Archives of neurology.

[56]  G. Comi,et al.  Quantification of cervical cord pathology in primary progressive MS using diffusion tensor MRI , 2005, Neurology.

[57]  Marco Rovaris,et al.  Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI , 2005, NeuroImage.

[58]  C H Polman,et al.  MR spectroscopic evidence for glial increase but not for neuro‐axonal damage in MS normal‐appearing white matter , 2005, Magnetic resonance in medicine.

[59]  Daniel Pelletier,et al.  Corpus callosum axonal injury in multiple sclerosis measured by proton magnetic resonance spectroscopic imaging. , 2004, Archives of neurology.

[60]  Alan J. Thompson,et al.  Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosis , 2004, NeuroImage.

[61]  R. Hohlfeld.  Immunologic factors in primary progressive multiple sclerosis , 2004, Multiple sclerosis.

[62]  Sajja B Rao,et al.  Multicentre proton magnetic resonance spectroscopy imaging of primary progressive multiple sclerosis , 2004, Multiple sclerosis.

[63]  B. Serafini,et al.  Detection of Ectopic B‐cell Follicles with Germinal Centers in the Meninges of Patients with Secondary Progressive Multiple Sclerosis , 2004, Brain pathology.

[64]  I. Elovaara,et al.  Volumetric quantitation by MRI in primary progressive multiple sclerosis: volumes of plaques and atrophy correlated with neurological disability , 2003, European journal of neurology.

[65]  A. Thompson,et al.  Primary progressive multiple sclerosis: a 5-year clinical and MR study. , 2003, Brain : a journal of neurology.

[66]  Frederik Barkhof,et al.  Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. , 2003, Archives of neurology.

[67]  F. Barkhof,et al.  The effect of interferon β-1b on quantities derived from MT MRI in secondary progressive MS , 2003, Neurology.

[68]  Wolfgang Brück,et al.  Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. , 2002, Brain : a journal of neurology.

[69]  Massimo Filippi,et al.  Irreversible disability and tissue loss in multiple sclerosis: a conventional and magnetization transfer magnetic resonance imaging study of the optic nerves. , 2002, Archives of neurology.

[70]  D. Clayton,et al.  Multiple sclerosis in sibling pairs: an analysis of 250 families , 2001, Journal of neurology, neurosurgery, and psychiatry.

[71]  K. Becker.  APOE genotype is a major predictor of long-term progression of disability in MS , 2001, Neurology.

[72]  R. Kinkel,et al.  Axonal loss in normal-appearing white matter in a patient with acute MS , 2001, Neurology.

[73]  A J Thompson,et al.  Diagnostic criteria for primary progressive multiple sclerosis: A position paper , 2000, Annals of neurology.

[74]  M W Weiner,et al.  1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS , 2000, Multiple sclerosis.

[75]  J K Udupa,et al.  Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis. , 2000, Radiology.

[76]  Ganter,et al.  Spinal cord axonal loss in multiple sclerosis: a post‐mortem study , 1999, Neuropathology and applied neurobiology.

[77]  Geoff J. M. Parker,et al.  1H Magnetic resonance spectroscopy of normal appearing white matter in primary progressive multiple sclerosis , 1999, Journal of Neurology.

[78]  P M Matthews,et al.  Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. , 1998, Brain : a journal of neurology.

[79]  W. Brück,et al.  Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions , 1998, Multiple sclerosis.

[80]  G. Barker,et al.  MRI dynamics of brain and spinal cord in progressive multiple sclerosis. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[81]  A J Thompson,et al.  A comparison of the pathology of primary and secondary progressive multiple sclerosis. , 1994, Brain : a journal of neurology.

[82]  A. Thompson,et al.  Major differences in the dynamics of primary and secondary progressive multiple sclerosis , 1991, Annals of neurology.

[83]  A. Thompson,et al.  Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study. , 1990, BMJ.

[84]  B Bass,et al.  The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. , 1989, Brain : a journal of neurology.

[85]  I. T. Draper.  MULTIPLE SCLEROSIS: A REAPPRAISAL , 1973, The Medical journal of Australia.

[86]  C. Pallis.  SPASTIC PARAPLEGIA OF MIDDLE AGE , 1955 .

[87]  J. Marshall.  Spastic paraplegia of middle age; a clinicopathological study. , 1955, Lancet.

[88]  R. Reynolds,et al.  Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. , 2007, Brain : a journal of neurology.

[89]  J. Baskerville,et al.  The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease. , 2006, Brain : a journal of neurology.

[90]  J. Dehmeshki,et al.  The normal appearing grey matter in primary progressive multiple sclerosis , 2003, Journal of Neurology.

[91]  G Cutter,et al.  Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients. , 2000, Multiple sclerosis.

[92]  F. Barkhof,et al.  Cortical lesions in multiple sclerosis. , 1999, Brain : a journal of neurology.

[93]  J. Baskerville,et al.  The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. , 1999, Brain : a journal of neurology.

[94]  Kenneth J. Smith.  Conduction properties of central demyelinated and remyelinated axons, and their relation to symptom production in demyelinating disorders , 1994, Eye.

[95]  W. Mcdonald,et al.  Diagnosis and classification of multiple sclerosis. , 1977, British medical bulletin.